ANDA 75351, held by Novitium Pharma. Aspirin; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 15, 2026, ANDA 75351 (Butalbital, Aspirin, Caffeine, And Codeine Phosphate), held by Novitium Pharma, was first approved by FDA on Mar 5, 1999, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 5, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Aspirin, Caffeine, And Codeine Phosphate325MG;50MG;40MG;30MG · capsule;oral | Aspirin; Butalbital; Caffeine; Codeine Phosphate | Discontinued |
| Jun 18, 2026 | Supplement 12REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 11Labeling · Standard review | Approved | None posted |
| Apr 30, 2025 | Supplement 9REMS | Approved | None posted |
| Nov 21, 2024 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 23, 2024 | Supplement 8Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 4, 2023 | Supplement 4Labeling · Standard review | Approved | None posted |
| Dec 4, 2023 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 5REMS · Standard review | Approved | None posted |
| Jul 18, 2002 | Supplement 2Manufacturing | Approved | None posted |
| Jun 7, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Mar 5, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters